Fingerprint
Dive into the research topics of 'Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.
J. P. Zajicek*, H. P. Sanders, D. E. Wright, P. J. Vickery, W. M. Ingram, S. M. Reilly, A. J. Nunn, L. J. Teare, P. J. Fox, A. J. Thompson
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review